Skip to main content
Smart Investors Daily
AB

NASDAQ · ABP

Abpro Corporation

Healthcare · Biotechnology

$0.52

Up+$0.00 (+0.00%)

Updated Aug 14, 2026, 4:49 PM

SID Score

2.5/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
538.98K
P/E ratio
-0.05
Dividend yield
0.00%
52-week range
$0.52 – $13.65
Volume
3.26M
Avg. volume
1.69M

Price performance

ABP price history

1M range · 0 trading sessions · Daily adjusted prices

ABP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ABP news

The latest Smart Investors Daily articles mentioning ABP.

ABP research

Overview

Company profile and research snapshot.

Company profile

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
ABP recent ratings
DateFirmRatingTarget
Oct 21, 2025Maxim GroupHold
Feb 24, 2025Maxim GroupBuy
Open full forecast

News briefing

No generated briefing is available yet.

ChartMill · Feb 11, 2026

Top stock movements in today's session.

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.